Kalyan Roy: Swirling as a Simple Indicator of Platelet Quality
Kalyan Roy, Transfusion Medicine Specialist at Square Hospitals LTD, shared a post on LinkedIn:
”What if a simple visual check could reliably indicate platelet quality – without complex testing?
Ensuring the quality and viability of platelet concentrates (PCs) remains a fundamental pillar of modern transfusion medicine, directly influencing patient safety and clinical outcomes.
A large multicenter study across 13 centers, evaluating over 5,000 platelet units, highlights a valuable and practical insight: the visual assessment of ‘swirling’ can serve as a reliable, real-time indicator of platelet quality.
Key Observations from the Study
- Strong correlation with optimal pH
Swirling was consistently associated with pH levels between 6.7–7.5, a range linked to effective in vivo platelet survival. - Indicator of compromised platelet integrity
Approximately 69% of units lacking swirling showed pH values outside the acceptable physiological range (<6.4 or >7.6), suggesting reduced viability. - Unexplained subset requiring further research
Nearly 20% of non-swirling units had normal pH values, indicating additional underlying factors influencing platelet quality.
Why This Matters
Swirling reflects the preservation of the platelet’s discoid morphology, essential for optimal hemostatic function.
Its absence often signals transformation into a spherical form-historically associated with diminished viability and clinical performance.
Implications for Clinical Practice
- Enables rapid, bedside-compatible evaluation
- Offers a non-invasive and cost-effective alternative to complex laboratory assays
- Improves operational efficiency in transfusion services
- Maintains high standards of patient safety with minimal resource burden
In an era where healthcare systems must balance efficiency with excellence, adopting validated, low-cost tools like swirling assessment can significantly enhance routine platelet quality monitoring.”
Other posts featuring Kalyan Roy on Hemostasis Today.
-
Jul 13, 2026, 16:06Dino Mehic: Honored to Receive the ISTH Early Career Top Reviewer Awards
-
Jul 13, 2026, 16:01Advancing DIC Diagnosis in Cirrhosis Through Disease-Specific Risk Stratification – JTH
-
Jul 13, 2026, 15:52Joshua Muia: Presenting Our Research on ADAMTS13/VWF Dysregulation in Sepsis at ISTH 2026
-
Jul 13, 2026, 15:42Marc Carrier: Important New Data From the API-CAT Trial on Recurrent VTE During Extended Apixaban Therapy
-
Jul 13, 2026, 15:23Akshat Jain: 5 Key Clinical Takeaways from ISTH 2026
-
Jul 13, 2026, 15:15Alfonso J. Tafur: Insights on Periprocedural DOAC Management in Atrial Fibrillation at ISTH 2026
-
Jul 13, 2026, 14:42Bruno Pougault: The Global Momentum Behind Innovation in Thrombosis and Hemostasis
-
Jul 13, 2026, 14:34Julie Vassart: Optimizing DOAC Detection in an Evolving Anticoagulant Landscape at ISTH 2026
-
Jul 13, 2026, 13:57Heghine Khachatryan: The Diagnostic Dilemma of Non-Criteria Obstetric APS